Effect of long-term antihypertensive treatment on white-coat hypertension

Giuseppe Mancia, Rita Facchetti, Gianfranco Parati, Alberto Zanchetti

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Limited evidence is available on the extent and frequency by which antihypertensive treatment lowers office blood pressure (BP) in white-coat hypertension (WCH). Data are even more scanty and discrepant on the corresponding effect on ambulatory BP (ABP). In the hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA), office and ABP were measured before treatment and at 6-month (office BP) or 12-month (ABP) intervals during the 4-year administration of calcium channel blocker-based or β-blocker-based treatment. The two groups were pooled and data were analyzed separately in patients with both office and ABP elevation (n=1670; sustained hypertension) or WCH (n=251; office BP elevation only). In sustained hypertension, office and 24-hour mean systolic BP were both markedly reduced through the treatment period, the mean change being -20.0±12.5 and -10.1±11.0 mm Hg, respectively (P

Original languageEnglish
Pages (from-to)1388-1398
Number of pages11
JournalHypertension
Volume64
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

White Coat Hypertension
Antihypertensive Agents
Blood Pressure
Therapeutics
Hypertension
Calcium Channel Blockers
Atherosclerosis

Keywords

  • Ambulatory blood pressure monitoring
  • Antihypertensive agents
  • Hypertension

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Effect of long-term antihypertensive treatment on white-coat hypertension. / Mancia, Giuseppe; Facchetti, Rita; Parati, Gianfranco; Zanchetti, Alberto.

In: Hypertension, Vol. 64, No. 6, 2014, p. 1388-1398.

Research output: Contribution to journalArticle

Mancia, Giuseppe ; Facchetti, Rita ; Parati, Gianfranco ; Zanchetti, Alberto. / Effect of long-term antihypertensive treatment on white-coat hypertension. In: Hypertension. 2014 ; Vol. 64, No. 6. pp. 1388-1398.
@article{1b5787b0b4d7421089030b3e69fc0ff5,
title = "Effect of long-term antihypertensive treatment on white-coat hypertension",
abstract = "Limited evidence is available on the extent and frequency by which antihypertensive treatment lowers office blood pressure (BP) in white-coat hypertension (WCH). Data are even more scanty and discrepant on the corresponding effect on ambulatory BP (ABP). In the hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA), office and ABP were measured before treatment and at 6-month (office BP) or 12-month (ABP) intervals during the 4-year administration of calcium channel blocker-based or β-blocker-based treatment. The two groups were pooled and data were analyzed separately in patients with both office and ABP elevation (n=1670; sustained hypertension) or WCH (n=251; office BP elevation only). In sustained hypertension, office and 24-hour mean systolic BP were both markedly reduced through the treatment period, the mean change being -20.0±12.5 and -10.1±11.0 mm Hg, respectively (P",
keywords = "Ambulatory blood pressure monitoring, Antihypertensive agents, Hypertension",
author = "Giuseppe Mancia and Rita Facchetti and Gianfranco Parati and Alberto Zanchetti",
year = "2014",
doi = "10.1161/HYPERTENSIONAHA.114.04278",
language = "English",
volume = "64",
pages = "1388--1398",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Effect of long-term antihypertensive treatment on white-coat hypertension

AU - Mancia, Giuseppe

AU - Facchetti, Rita

AU - Parati, Gianfranco

AU - Zanchetti, Alberto

PY - 2014

Y1 - 2014

N2 - Limited evidence is available on the extent and frequency by which antihypertensive treatment lowers office blood pressure (BP) in white-coat hypertension (WCH). Data are even more scanty and discrepant on the corresponding effect on ambulatory BP (ABP). In the hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA), office and ABP were measured before treatment and at 6-month (office BP) or 12-month (ABP) intervals during the 4-year administration of calcium channel blocker-based or β-blocker-based treatment. The two groups were pooled and data were analyzed separately in patients with both office and ABP elevation (n=1670; sustained hypertension) or WCH (n=251; office BP elevation only). In sustained hypertension, office and 24-hour mean systolic BP were both markedly reduced through the treatment period, the mean change being -20.0±12.5 and -10.1±11.0 mm Hg, respectively (P

AB - Limited evidence is available on the extent and frequency by which antihypertensive treatment lowers office blood pressure (BP) in white-coat hypertension (WCH). Data are even more scanty and discrepant on the corresponding effect on ambulatory BP (ABP). In the hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA), office and ABP were measured before treatment and at 6-month (office BP) or 12-month (ABP) intervals during the 4-year administration of calcium channel blocker-based or β-blocker-based treatment. The two groups were pooled and data were analyzed separately in patients with both office and ABP elevation (n=1670; sustained hypertension) or WCH (n=251; office BP elevation only). In sustained hypertension, office and 24-hour mean systolic BP were both markedly reduced through the treatment period, the mean change being -20.0±12.5 and -10.1±11.0 mm Hg, respectively (P

KW - Ambulatory blood pressure monitoring

KW - Antihypertensive agents

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=84922480151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922480151&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.114.04278

DO - 10.1161/HYPERTENSIONAHA.114.04278

M3 - Article

VL - 64

SP - 1388

EP - 1398

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -